Assessment of ICD eligibility in non-ischaemic cardiomyopathy patients: a position statement by the Task Force of the Dutch Society of Cardiology

• DOI: 10.1007/s12471-024-01859-7
• Publication Date: 2024-04-18T14:01:48Z
• Authors: Anne-Lotte C. J. ...; Tom E. Verstraelen; Lieselot van Erven; Joan G. Meeder; Dominic A. Theuns; Kevin Vernooy; Arthur A. M. Wilde; Alexander H. Maass; Cornelis P. Allaart
• Keywords: Ischemic Cardiomyopathy

International guidelines recommend implantation of an implantable cardioverter-defibrillator (ICD) in non-ischaemic cardiomyopathy (NICM) patients with a left ventricular ejection fraction (LVEF) below 35% despite optimal medical therapy and life expectancy more than 1 year good functional status. We propose refinement these recommendations NICM, careful consideration additional risk parameters for both arrhythmic non-arrhythmic death. These include late gadolinium enhancement on cardiac magnetic resonance imaging genetic testing high-risk variants to further assess risk, age, comorbidities sex assessment mortality risk. Moreover, several modifiers should be taken into account, such as concomitant arrhythmias that may affect LVEF (atrial fibrillation, premature beats) resynchronisation therapy. Even though currently no valid cut-off values have been established, the proposed approach provides risks result withholding ICD low substantial